Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
Crossref DOI link: https://doi.org/10.1007/s12032-018-1187-3
Published Online: 2018-08-03
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Helbig, Grzegorz http://orcid.org/0000-0003-3703-1268
Text and Data Mining valid from 2018-08-03
Article History
Received: 28 June 2018
Accepted: 31 July 2018
First Online: 3 August 2018
Compliance with ethical standards
:
: The author disclosed no conflict of interest.